Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Other Working Capital Changes (2024 - 2025)

Caris Life Sciences has reported Other Working Capital Changes over the past 2 years, most recently at $345000.0 for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $345000.0 for Q4 2025, up 144.92% from a year ago — trailing twelve months through Dec 2025 was $2.9 million (changed N/A YoY), and the annual figure for FY2025 was $5.1 million, up 265.77%.
  • Other Working Capital Changes for Q4 2025 was $345000.0 at Caris Life Sciences, down from $2.5 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for CAI hit a ceiling of $2.5 million in Q3 2025 and a floor of -$768000.0 in Q4 2024.